Area of Haemato-Oncology

"Our increased knowledge and advances in treatment with immunotherapy and advanced therapies have transformed the medical care of patients who suffer from haematological cancer in recent years".

DR. FELIPE PRÓSPER
SPECIALIST. AREA OF HAEMATO-ONCOLOGY

The specialists of renowned national and international prestige integrate The Area of Haemato-Oncology of the Clinic using diagnostic techniques and new personalized treatments in their healthcare work, which allows for a more precise and rapid diagnosis of malignant blood diseases.

The joint work of the medical and the researching personnel facilitates the development and the application of the new treatments and at the same time the precise evaluation of the result of the treatments.

We are experts in the development of treatments, which include the transplantation of hemapoietic progenitors, adoptive cellular immunotherapies such as CAR-T cells, dendritic cell vaccines, or activated lymphocytes for the treatment of infections. These treatments are developed jointly with the Cellular Therapy Area

Having headed some of the clinical trials that have led to the approval of new drugs such as Panibinostar, Lenalidomida, Carfilzomib or Daratumumab, we are an international benchmark centre in the field of lymphomas, myeloid neoplasms and mainly in myelomas and monoclonal gammopathies.

Imagen del icono de la consulta de Segunda Opinión. Clínica Universidad de Navarra

Do you need a remote second opinion?

Our professionals will provide you with a medical evaluation without you having to leave your home.

Comprehensive care for our patients

IN NAVARRE AND MADRID

DISEASES

TREATMENTS

Do you need to request a consultation with one of our specialists?

Learn more about our clinical trials

New therapeutic possibilities and advances for our patients

Myeloma and monoclonal gammopathies

Lymphomas and solid tumours

Myelodysplastic, myeloproliferative syndromes and acute leukemias

A multidisciplinary team of renowned prestige being at the forefront

AT THE FOREFRONT

Advanced Therapy Unit

The Advanced Therapies Unit of Clínica Universidad de Navarra has been established in order to deal exclusively with cellular therapies against cancer and other diseases of the immune system, favouring their administration and seeking to increase the safety of these treatments.

A multidisciplinary team of highly specialised nurses together with physicians from all the specialities involved in the approach to those treatments that depend on advanced therapy drugs and immunotherapy

PERSONALISED TREATMENT

Therapeutic advances

Our priority is to provide the patient who comes to our clinic with comprehensive information based on precise molecular diagnosis, therapeutic guidance including the possibility of receiving state-of-the-art treatments, as well as promising new drugs in the context of clinical trials and human support from our medical and nursing personnel.


GMP Cell Therapy Laboratory

This laboratory produces advanced therapy medicines under good manufacturing practices and is authorised by the Spanish Agency for Medicines and Health Products.


Specialized Nursing

Its role is focused on the monitoring of the therapeutic process, the palliation of possible adverse symptoms caused by the medication and the prevention of possible complications.


Excellence in research

The Clínica Universidad de Navarra is a pioneer in the field of cancer research and the treatment of other diseases related to the immune system.

Imagen de la fachada de consultas de la sede en Pamplona de la Clínica Universidad de Navarra

Why choose the Clinic?

  • International reference multidisciplinary team.
  • Highly specialised nursing team.
  • First GMP Cell Therapy Laboratory accredited in a hospital within the National Health System.

CIMA UNIVERSIDAD DE NAVARRA

Research and assistance

The collaborative group of professionals from the CIMA Universidad de Navarra and Clinic aims to understand the mechanism of transformation of normal blood cells into tumour cells in order to develop more effective treatments.

In the laboratories of the Cima, the origin of haematological diseases is studied in order to make the transition to clinical care through clinical trials and the development of new drugs.

We help our patients overcome their stories

Your testimonials encourage us to continue improving our services.

Safer than ever to continue taking care of you

We update safety protocols weekly with the latest scientific evidence and the knowledge of the best international centers with which we collaborate.